Bio-Techne
TECH
#1659
Rank
ยฃ8.10 B
Marketcap
ยฃ51.24
Share price
-0.87%
Change (1 day)
-9.71%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of December 2024 : ยฃ0.31 Billion

According to Bio-Techne's latest financial reports the company's total debt is ยฃ0.31 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2024)

Total debt by year

Year Total debt Change
2023-06-30ยฃ0.36 B34.23%
2022-06-30ยฃ0.26 B-11.56%
2021-06-30ยฃ0.30 B-13.73%
2020-06-30ยฃ0.35 B-11.5%
2019-06-30ยฃ0.39 B55.05%
2018-06-30ยฃ0.25 B-2.86%
2017-06-30ยฃ0.26 B273.49%
2016-06-30ยฃ70.74 M44.49%
2015-06-30ยฃ48.96 M544.21%
2014-06-30ยฃ7.6 M
2006-06-30ยฃ7.26 M-11.05%
2005-06-30ยฃ8.16 M-6.29%
2004-06-30ยฃ8.71 M-15.94%
2003-06-30ยฃ10.36 M-12%
2002-06-30ยฃ11.77 M-11.97%
2001-06-30ยฃ13.37 M2.41%
2000-06-30ยฃ13.06 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ยฃ27.87 B 8,837.13%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.09 B 251.31%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ14.80 B 4,647.33%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ13.83 B 4,335.03%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.51 B 385.88%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
ยฃ15.21 B 4,777.67%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.57 M-99.17%๐Ÿ‡บ๐Ÿ‡ธ USA